首页> 美国卫生研究院文献>Neuro-Oncology >P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)
【2h】

P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)

机译:P14.25 18F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET / CT)在原发灶未知(CUPS)的脑转移(BM)患者中检测原发灶和分期

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: In 30% of patients with brain metastasis (BM), BM are the first clinical manifestation of systemic malignancy, referred to as BM from cancer of unknown primary site (BM-CUPS). The value of 18F-fluordesoxyglucose positron emission tomography (FDG-PET)/CT in the work-up of BM-CUPS patients remains to be defined. >Patients and methods: We screened 566 patients operated for BM at the University Hospital Zurich between 2004 and 2014 and identified 127 BM-CUPS patients. Two validation cohorts (n=100 and 120 patients) from independent centers were available. >Results: FDG-PET/CT was not superior to CT in localizing the primary lesion as CT (FDG-PET/CT: 73/78, 93.6%; CT: n=70/78, 89.7%; p=0.25, McNemar’s test). Thirty-six of 64 patients (56.3%) showed the same result in spotting the primary tumor and other extracranial lesions. FDG-PET/CT identified additional lesions suspicious for extracranial metastases in 28 patients (43.7%). The graded prognostic assessment (GPA) score was determined post-hoc to objectify clinical relevance of additional findings. Information from CT alone or FDG-PET/CT was used to assess extracranial metastases. Median GPA was 3 for CT vs. 2.5 for PET/CT (p= 3.8x10-5), resulting in a predicted survival of 5.3 vs. 3.8 months (p= 6.1x10-5; Wilcoxon’s test). Sensitivity of CT and FDG-PET/CT and staging capabilities were comparable in all cohorts. >Conclusions: FDG-PET/CT shows similar sensitivity to detect the primary tumor in BM-CUPS patients as CT, but improves the accuracy of staging. GPA scores and predicted survival differ significantly when calculated based on CT versus FDG-PET/CT. FDG-PET/CT should be prioritized for planning the diagnostic algorithm of BM-CUPS patients and redundant CT imaging should be avoided. Further, randomized trials on BM patients should consider stratification for the respective staging methods when employing GPA scores.
机译:>背景:在30%的脑转移(BM)患者中,BM是系统性恶性肿瘤的首例临床表现,称为原发性未知部位癌症(BM-CUPS)引起的BM。 BM-CUPS患者的 18 氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)/ CT的价值尚待确定。 >患者和方法:我们在2004年至2014年之间对苏黎世大学医院的566例行BM手术的患者进行了筛查,确定了127例BM-CUPS患者。来自独立中心的两个验证队列(n = 100和120位患者)可用。 >结果: FDG-PET / CT在将原发灶定位为CT方面并不优于CT(FDG-PET / CT:73 / 78,93.6%; CT:n = 70 / 78,89.7% ; p = 0.25,McNemar检验)。 64名患者中有36名(56.3%)在发现原发性肿瘤和其他颅外病变方面显示出相同的结果。 FDG-PET / CT在28例患者中发现了可疑的颅外转移灶(43.7%)。事后确定分级的预后评估(GPA)评分,以客观化其他发现的临床相关性。仅使用CT或FDG-PET / CT的信息来评估颅外转移。 CT的GPA中位数为3,而PET / CT的GPA中位数为2.5(p = 3.8x10 -5 ),因此预计存活时间为5.3与3.8个月(p = 6.1x10 -5 ; Wilcoxon的测试)。在所有队列中,CT和FDG-PET / CT的敏感性和分期能力均相当。 >结论: FDG-PET / CT在检测BM-CUPS患者的原发肿瘤方面的敏感性与CT相似,但提高了分期的准确性。当基于CT与FDG-PET / CT进行计算时,GPA得分和预测的存活率显着不同。应优先考虑使用FDG-PET / CT来规划BM-CUPS患者的诊断算法,并应避免多余的CT成像。此外,在采用GPA评分时,针对BM患者的随机试验应考虑分层方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号